.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Researchers recently investigated a multi-strain synbiotic to improve Salmonella Enteritidis prevention in poultry. This development is highly significant for doctors in India. Specifically, it addresses the rising threat of foodborne zoonoses and antimicrobial resistance. By reducing pathogen carriage in chickens, we can better protect human health across the country. This strategy aligns with the One Health initiative to control infections at their source.
The formulation combines three specific lactic acid bacteria strains known for their probiotic properties. These include Enterococcus faecium, Ligilactobacillus salivarius, and Lactobacillus crispatus. Additionally, the synbiotic contains prebiotics such as raffinose and molasses. This combination creates a hostile environment for pathogens within the avian gut. The researchers confirmed that these strains work together without antagonism to maximize protective effects.
In vitro tests showed clear bactericidal activity against S. Enteritidis. Furthermore, ex vivo assays indicated that the synbiotic prevents bacterial attachment to intestinal walls. Most importantly, in vivo trials in broiler chicks showed a dramatic reduction in infection rates. Specifically, treated birds had only a 30% infection rate compared to 100% in the control group. Consequently, early-life administration provides a sustainable way to decrease the reservoir of Salmonella in the food chain.
For Indian clinicians, these findings suggest a potential decrease in the burden of non-typhoidal salmonellosis. This research offers a viable alternative to traditional antibiotics as growth promoters. Moreover, it helps mitigate the spread of multidrug-resistant bacteria from poultry farms to patients. Therefore, improving Salmonella Enteritidis prevention in livestock is a critical step in modern infectious disease management.
Synbiotics combine probiotics and prebiotics to create a synergistic effect. They inhibit pathogen attachment to the intestinal epithelium and exert direct bactericidal activity, significantly lowering infection rates in the host.
Salmonella Enteritidis is a major cause of foodborne gastroenteritis in humans. Since poultry products are a primary transmission vehicle, controlling the pathogen at the source reduces the public health burden of zoonotic infections and antibiotic resistance.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. It is intended for healthcare professionals to stay updated on related scientific advancements. Refer to the latest local and national guidelines for clinical practice.
References
Babot JD et al. Preventive effects of synbiotic supplementation against Salmonella Enteritidis infection in broiler chickens. Can J Microbiol. 2026 Mar 19. doi: 10.1139/cjm-2025-0283. PMID: 41855562.
Shil S et al. Antimicrobial Resistance in Salmonella from Indian Poultry: Trends, Challenges, and One Health Perspectives. Journal of Pure and Applied Microbiology. 2026 Mar 11.
World Health Organization. Salmonella (non-typhoidal) Fact Sheet. 2024.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A study highlights how early-life synbiotic administration significantly reduces Salmonella Enteritidis in broiler chicks, supporting food safety in India....
5 months ago
Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
